Partners

Abbvie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com

Boehringer Ingelheim

The Boehringer Ingelheim group is a research-driven company dedicated to researching and developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.
Our business areas consist of Human Pharmaceuticals and Animal Health. We have more than 46,000 employees in 140 affiliated companies worldwide, research and development (R&D) facilities at six sites worldwide, and 20 production plants in 13 countries. R&D expenditure in Prescription Medicines corresponds to 22.5% of net sales.
Our headquarter is at Ingelheim, the German town where the family-owned company was founded in 1885.

Canada Foundation for Innovation

Created by the Government of Canada in 1997, the CFI strives to build our nation’s capacity to undertake world-class research and technology development that benefits Canadians and the global community. Thanks to CFI investments in state-of-the-art infrastructure, Canadian universities, colleges, research hospitals and non-profit research institutions are attracting and retaining the world’s top research talent, training the next generation of researchers, supporting private-sector innovation and creating high-quality jobs that strengthen Canada’s position in today’s knowledge economy.

The São Paulo Research Foundation (FAPESP)

is a public institution with the mission of supporting science and technology research and development in the state of São Paulo. FAPESP selects and supports research projects in all fields of knowledge submitted by researchers associated with institutions of higher education and research in the state of São Paulo. The selection of projects is conducted through peer review, the methodology based on reviews issued by Brazilian and foreign researchers not associated with the Foundation. In 2014, the Foundation disbursed US$ 490 million to fund science and technology research projects. For more information, visit www.fapesp.br/en.

Genome Canada

is a not-for-profit organization that invests in genomics research to generate economic and social benefits for Canadians. Genome Canada builds bridges between government, academia and industry to forge a genomics-based public-private innovation enterprise focused on key life science sectors. It develops these partnerships to invest in and manage large-scale research and translate discoveries into commercial opportunities, new technologies, applications and solutions. For more information, visit www.genomecanada.ca

Janssen, Pharmaceutical Companies of Johnson & Johnson

Our strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. We leverage our world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience and oncology. We think of the world as our laboratory and we look for innovation wherever it exists. This drives our relentless search for the best science, and our pursuit of collaborations and partnerships. www.jnjpharmarnd.com

Merck

Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on TwitterFacebook and YouTube.

Novartis

is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world.

The Ontario Ministry of Research, Innovation and Science (MRIS)

was created to focus on the government's commitment to innovation as the driver of growth across all sectors of the economy. The Ministry's mandate is to develop an integrated innovation strategy and guide its delivery; invest in both policies and programs to deliver on the innovation strategy; and foster a culture of innovation and showcase Ontario's innovative culture, nationally and internationally.

Pfizer

is the world's leading biopharmaceutical company. Pfizer’s mission is to discover and develop innovative medicines and other products to improve the quality of life of people and animals around the world. Our diversified health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.

Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

The Wellcome Trust

is the largest charity in the UK and the second largest medical research charity in the world. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and well-being.

 

Funding acknowledgement

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust.

 

glqxz9283 sfy39587stf02 mnesdcuix8
sfy39587stf03